BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 9327650)

  • 1. Psychotropic medication use in people with developmental disabilities.
    Curtis JL
    Md Med J; 1997 Oct; 46(9):481-5. PubMed ID: 9327650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naltrexone treatment of self-injurious behavior.
    Godart NT; Agman G; Perdereau F; Jeammet P
    J Am Acad Child Adolesc Psychiatry; 2000 Sep; 39(9):1076-8. PubMed ID: 10986803
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of previously undiagnosed psychiatric disorders in persons with developmental disabilities decreased or eliminated self-injurious behavior.
    Tsiouris JA; Cohen IL; Patti PJ; Korosh WM
    J Clin Psychiatry; 2003 Sep; 64(9):1081-90. PubMed ID: 14628984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy of irritability in pervasive developmental disorders.
    Stigler KA; McDougle CJ
    Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):739-52, vii-viii. PubMed ID: 18775367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral self-injurious behaviors in patients with developmental disabilities.
    Romer M; Dougherty NJ
    Dent Clin North Am; 2009 Apr; 53(2):339-50, x-xi. PubMed ID: 19269402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.
    Aman MG; Gharabawi GM;
    J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of psychotropic medications in children with developmental disabilities.
    Calles JL
    Pediatr Clin North Am; 2008 Oct; 55(5):1227-40, ix. PubMed ID: 18929062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of psychotropic agents for children with psychosomatic problems and developmental disorders].
    Ishizaki Y
    Nihon Rinsho; 2012 Jan; 70(1):130-4. PubMed ID: 22413507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychological and pharmacological treatments of mood and anxiety disorders during pregnancy and postpartum. Review and synthesis].
    Dayan J; Yoshida K
    J Gynecol Obstet Biol Reprod (Paris); 2007 Oct; 36(6):530-48. PubMed ID: 17616265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs for psychiatric disorders.
    Med Lett Drugs Ther; 1986 Oct; 28(725):99-106. PubMed ID: 3762490
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups.
    Curran S; Turner D; Musa S; Wattis J
    Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designs and analyses of psychotropic and behavioral interventions for the treatment of problem behavior among people with intellectual and developmental disabilities.
    Courtemanche AB; Schroeder SR; Sheldon JB
    Am J Intellect Dev Disabil; 2011 Jul; 116(4):315-28. PubMed ID: 21740259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychopharmacological treatment of mood and anxiety disorders during pregnancy.
    Krüger S
    Handb Exp Pharmacol; 2012; (214):279-305. PubMed ID: 23027456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotropic drug use in intellectually disabled group-home residents with behavioural problems.
    Stolker JJ; Koedoot PJ; Heerdink ER; Leufkens HG; Nolen WA
    Pharmacopsychiatry; 2002 Jan; 35(1):19-23. PubMed ID: 11819154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of psychotropic drugs in epilepsy: what every neurologist should know.
    Kanner AM
    Semin Neurol; 2008 Jul; 28(3):379-88. PubMed ID: 18777484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward a functional analysis of drug treatment for behavior problems of people with developmental disabilities.
    Schaal DW; Hackenberg T
    Am J Ment Retard; 1994 Sep; 99(2):123-40. PubMed ID: 7803030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal prescribing patterns for psychoactive medications in community-based individuals with developmental disabilities: utilization of pharmacy records.
    Lott IT; McGregor M; Engelman L; Touchette P; Tournay A; Sandman C; Fernandez G; Plon L; Walsh D
    J Intellect Disabil Res; 2004 Sep; 48(Pt 6):563-71. PubMed ID: 15312057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of different psychotropic drugs on psychotic anxiety.
    Nahunek K; Svestka J; Ceskova E
    Agressologie; 1981 Nov; 22(D):11-3. PubMed ID: 7332036
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.